Glycopyrrolate and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data


Paranasal sinus hypersecretion is reported only by a few people who take Glycopyrrolate.

The phase IV clinical study analyzes which people take Glycopyrrolate and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 3,707 people who have side effects while taking Glycopyrrolate from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 01, 2022

3,707 people reported to have side effects when taking Glycopyrrolate.
Among them, 1 person (0.03%) has Paranasal sinus hypersecretion.

What is Glycopyrrolate?

Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 3,772 Glycopyrrolate users for its effectiveness, alternative drugs and more.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 729 drugs and 393 conditions by eHealthMe.

Number of Glycopyrrolate and Paranasal sinus hypersecretion reports submitted per year:

Could Glycopyrrolate cause Paranasal sinus hypersecretion?

Gender of people who have Paranasal sinus hypersecretion when taking Glycopyrrolate *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Paranasal sinus hypersecretion when taking Glycopyrrolate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 100 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Glycopyrrolate *:

  1. Tagamet: 1 person, 100.00%
  2. Sinemet: 1 person, 100.00%
  3. Reglan: 1 person, 100.00%
  4. Protropin: 1 person, 100.00%
  5. Propulsid: 1 person, 100.00%
  6. Nutropin Aq: 1 person, 100.00%
  7. Nasacort: 1 person, 100.00%
  8. Lodosyn: 1 person, 100.00%
  9. Folate: 1 person, 100.00%
  10. Claritin: 1 person, 100.00%

Common side effects people have besides Paranasal sinus hypersecretion *:

  1. Weight Decreased: 1 person, 100.00%
  2. Vitamin D Decreased: 1 person, 100.00%
  3. Bone Density Decreased: 1 person, 100.00%
  4. Breathing Difficulty: 1 person, 100.00%
  5. Catheter Site Erythema (redness of skin at catheter site): 1 person, 100.00%
  6. Constipation: 1 person, 100.00%
  7. Gingival Hypertrophy (overgrowth of gums): 1 person, 100.00%
  8. Hand Fracture: 1 person, 100.00%
  9. Head Injury: 1 person, 100.00%
  10. Insulin-Like Growth Factor Increased: 1 person, 100.00%

Common conditions people have *:

  1. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 1 person, 100.00%
  2. Hyperreflexia (overactive or over responsive reflexes): 1 person, 100.00%
  3. Growth Hormone Deficiency: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glycopyrrolate and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Paranasal sinus hypersecretion and when was it recovered:

Expand to all the drugs that have ingredients of glycopyrrolate:

Alternative drugs to, pros and cons of Glycopyrrolate:

Common Glycopyrrolate side effects:

Browse all side effects of Glycopyrrolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Paranasal sinus hypersecretion treatments and more:

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

All the drugs that are associated with Paranasal sinus hypersecretion:

Common conditions associated with Paranasal sinus hypersecretion:

All the conditions that are associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Glycopyrrolate) and Glycopyrrolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: